Diabetes
Diabetes Market Research, Intelligence and Forescasts
In this section you will find information products, including market research, covering Diabetes research, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
|
Diabetes Market in UAE |
February 2010 | £330 |
|
Type 1 Diabetes Drug Pipeline Analysis and Market Forecasts to 2016 |
January 2010 | £1320 |
|
The Future of The Diabetes Care Devices Market to 2016 The Key Demand Drivers Remain Intact |
January 2010 | £2310 |
|
Type 2 Diabetes Drug Pipeline Analysis and Market Forecasts to 2016 |
January 2010 | £1320 |
|
Diabetes Market Forecast to 2015 |
January 2010 | £6600 |
|
Educating the Marketplace to Support Successful Diabetes Product Launches |
January 2010 | £5225 |
|
Hemoglobin A1c Monitoring Global Market Trends |
November 2009 | £1980 |
|
Diabetes Diagnostics A Global Market Perspective |
November 2009 | £1980 |
|
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010 |
November 2009 | £4950 |
|
Antidiabetics in Australia Market Forecast |
October 2009 | £3765 |
|
Commercial Insight: Antidiabetics in Australia Reimbursement status shapes novel classes |
October 2009 | £3765 |
|
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024 |
July 2009 | £1499 |
|
Insulin Delivery Devices Market Analysis and Future Forecast |
June 2009 | £495 |
|
Diabetes, Metabolic Syndrome and Cardiovascular Disease Reshaping Tomorrow's Diabetes Market |
April 2009 | £2245 |
|
Blood Glucose Testing and Diabetes Management |
April 2009 | £2245 |
|
The World Diabetes Market, 2007-2025 An Analysis of Diabetes Drug and Insulin Market |
March 2009 | £235 |
|
The Toolkit for Diabetes MSL Programs |
March 2009 | £5080 |
|
Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets |
March 2009 | £3965 |
|
Diabetes Drug Discoveries 2009: what the future holds |
February 2009 | £795 |
|
World Diabetes Market Analysis 2009-2023 |
February 2009 | £1499 |
|
China Diabetes Drug Market Report The Chinese Hospital Cancer Drug Utilization |
January 2009 | £5285 |
|
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Competitor Analysis |
November 2008 | £270 |
|
Sodium-dependent glucose (co-) transporter (SGLT) Inhibitors Competitor Analysis |
November 2008 | £90 |
|
GLP-1 Receptor Agonists Competitor Analysis |
November 2008 | £180 |
|
Diabetes Market Forecast to 2013 |
November 2008 | £6600 |
|
Emerging Diabetes Drugs Competitor Analysis |
November 2008 | £540 |
|
Stakeholder Opinions: Diabetic Renal Disease |
November 2008 | £1320 |
|
Dipeptidyl peptidase IV (DPP-IV) Inhibitors Competitor Analysis |
November 2008 | £135 |
|
Diabetes Drug Pipeline Competitor Analysis |
November 2008 | £1075 |
|
Insulin Competitor Analysis |
October 2008 | £360 |
|
Innovations in The Management of Diabetes Next generation treatments and market dynamics |
June 2008 | £1995 |
|
Textbook of Diabetes and Pregnancy |
February 2008 | £140 |
|
Clinical Protocols in Obstetrics and Gynecology |
February 2008 | £55 |
|
Diabetes Therapies & Diagnostics: Global Markets |
January 2008 | £3205 |
|
Diabetes Stakeholder Insight |
December 2007 | £5020 |
|
Type 1 Diabetes in Adults Principles and Practice |
November 2007 | £105 |
|
Type 2 Diabetes, 2nd edition Principles and Practice |
June 2007 | £100 |
|
Geriatric Diabetes |
May 2007 | £105 |
|
Islet Transplantation and Beta, Cell Replacement therapy |
April 2007 | £145 |
|
Diabetes and Diabetic Complications Major World Markets, 3rd Ed. |
March 2007 | £2640 |
|
Diabetes Drug Discoveries What the Future Holds |
January 2007 | £1495 |
|
Stakeholder Insight: Atherosclerosis HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment |
December 2006 | £5285 |
|
Commercial and Pipeline Perspectives: Obesity Lack of Reimbursement Limits Market Potential |
December 2006 | £3965 |
|
Stakeholder Insight: Atrial Fibrillation Limited efficacy and poor safety lead to bleak outlook |
October 2006 | £5285 |
|
Commercial Insight: Antihypertensives New challenges for a maturing market |
September 2006 | £5285 |
|
Pipeline Insight: Insulins Inhalable insulins unlikely to become blockbusters |
September 2006 | £3965 |
|
Pipeline Insight: Non-insulin Antidiabetics Type 2 diabetes unlikely to develop into a switch market |
August 2006 | £4290 |
|
Global Diabetes Market; The Therapeutics, Diagnostics and Complications |
August 2006 | £1650 |
|
Diabetes Market Outlook to 2011; The |
May 2006 | £1495 |
|
World Diabetes Market, The 2005-2011 |
March 2006 | £1499 |
|
Diabetes Monitoring Products & Therapies to 2008 |
February 2005 | £2710 |
|
Competitive Outlook on HCV What to Know & Expect in R&D and Business Development |
June 2004 | £895 |
|
International Textbook of Diabetes Mellitus |
April 2004 | £310 |
|
Diabetes in Focus Second edition |
July 2003 | £29.95 |
